Results 311 to 320 of about 497,452 (342)

Specific degrader for fusion oncokinase kills tumors and is augmented by bimodal degrader-siRNA

open access: yes
Shirani M   +8 more
europepmc   +1 more source

siRNA-Based Nanomedicine

Nanomedicine, 2013
By nature, cancer cells are the toughest cells against any treatment. The various available therapies would be much more effective at much lower dose if siRNA against the therapeutic resistance could be identified and successfully codelivered by nanocarriers such as polymer conjugation, micelles, liposomes, solid lipid nanoparticles, nanohydrogels and ...
Zhao, J., Mi, Y., Feng, S.-S.
openaire   +2 more sources

Chemical Modification of siRNA

Current Protocols in Nucleic Acid Chemistry, 2009
AbstractThe ability to manipulate the RNA interference (RNAi) machinery to specifically silence the expression of target genes could be a powerful therapeutic strategy. Since the discovery that RNAi can be triggered in mammalian cells by short double‐stranded RNAs (small interfering RNA, siRNA), there has been a tremendous push by researchers, from ...
Deleavey, Glen F.   +2 more
openaire   +4 more sources

Therapeutic siRNAs

Trends in Pharmacological Sciences, 2004
The ability of small-interfering RNAs (siRNAs) to silence gene expression in somatic mammalian cells has provided researchers with a novel tool to block the expression of disease-causing genes, provided that their mRNA sequences are known. siRNAs can be delivered to cells either exogenously as synthetic agents or endogenously as gene-encoding siRNAs ...
openaire   +2 more sources

siRNA technology

Molecular and Cellular Endocrinology, 2004
RNA interference (RNAi) represents a mechanism invented by nature to protect the genome. In the past few years the field has emerged at a surprisingly high pace. The underlying molecular mechanism of gene silencing provides us with short interfering RNAs (siRNAs) which allows to target any gene with high specificity and efficiency.
openaire   +2 more sources

siRNA Loaded-Exosomes

2021
Exosomes are membrane-bound vesicles (40-100 nm) of endocytic origin released by numerous cell types that act as natural carriers of mRNA, microRNA, and proteins between cells. We developed a new system that uses intravenous injection of modified exosomes for siRNA delivery into the brain.
Lydia Alvarez-Erviti, María Izco
openaire   +2 more sources

Preparation of siRNA Duplexes

Cold Spring Harbor Protocols, 2019
This protocol describes how to anneal synthetic sense and antisense siRNAs to form siRNA duplexes, as well as the analysis of siRNA duplexes using nondenaturing polyacrylamide gel electrophoresis.
Phillip D. Zamore, Chengjian Li
openaire   +3 more sources

Home - About - Disclaimer - Privacy